149 related articles for article (PubMed ID: 20472681)
41. Review: low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1.
Thangarajh M; Gutmann DH
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):241-53. PubMed ID: 22035280
[TBL] [Abstract][Full Text] [Related]
42. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
43. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
44. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
45. GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma.
Abel TW; Clark C; Bierie B; Chytil A; Aakre M; Gorska A; Moses HL
Mol Cancer Res; 2009 May; 7(5):645-53. PubMed ID: 19435821
[TBL] [Abstract][Full Text] [Related]
46. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
47. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
48. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
49. Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model.
Shah K; Hingtgen S; Kasmieh R; Figueiredo JL; Garcia-Garcia E; Martinez-Serrano A; Breakefield X; Weissleder R
J Neurosci; 2008 Apr; 28(17):4406-13. PubMed ID: 18434519
[TBL] [Abstract][Full Text] [Related]
50. Mouse models of glioma.
Stylli SS; Luwor RB; Ware TM; Tan F; Kaye AH
J Clin Neurosci; 2015 Apr; 22(4):619-26. PubMed ID: 25698543
[TBL] [Abstract][Full Text] [Related]
51. Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.
Gutmann DH
J Child Neurol; 2008 Oct; 23(10):1186-94. PubMed ID: 18952585
[TBL] [Abstract][Full Text] [Related]
52. Pediatric hemispheric high-grade glioma: targeting the future.
Coleman C; Stoller S; Grotzer M; Stucklin AG; Nazarian J; Mueller S
Cancer Metastasis Rev; 2020 Mar; 39(1):245-260. PubMed ID: 31989507
[TBL] [Abstract][Full Text] [Related]
53. Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice.
Taillandier L; Antunes L; Angioi-Duprez KS
J Neurosci Methods; 2003 May; 125(1-2):147-57. PubMed ID: 12763241
[TBL] [Abstract][Full Text] [Related]
54. Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model.
Moore LM; Holmes KM; Fuller GN; Zhang W
Chin J Cancer; 2011 Mar; 30(3):163-72. PubMed ID: 21352693
[TBL] [Abstract][Full Text] [Related]
55. Lentivirus vector‑mediated genetic manipulation of oncogenic pathways induces tumor formation in rabbit brain.
Ahmad F; Hyvärinen A; Pirinen A; Olsson V; Rummukainen J; Immonen A; Närväinen J; Tuunanen P; Liimatainen T; Kärkkäinen V; Koistinaho J; Ylä-Ηerttuala S
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846766
[TBL] [Abstract][Full Text] [Related]
56. B-cell lymphoma-2 promotes malignant progression in glioma.
Doucette TA; Rao G
Clin Neurosurg; 2011; 58():149-54. PubMed ID: 21916141
[No Abstract] [Full Text] [Related]
57. Modeling Gliomas Using Two Recombinases.
Hara T; Verma IM
Cancer Res; 2019 Aug; 79(15):3983-3991. PubMed ID: 31315836
[TBL] [Abstract][Full Text] [Related]
58. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
[TBL] [Abstract][Full Text] [Related]
59. A syngeneic mouse glioma model for study of glioblastoma therapy.
Weiner NE; Pyles RB; Chalk CL; Balko MG; Miller MA; Dyer CA; Warnick RE; Parysek LM
J Neuropathol Exp Neurol; 1999 Jan; 58(1):54-60. PubMed ID: 10068314
[TBL] [Abstract][Full Text] [Related]
60. Review: insights gained from modelling high-grade glioma in the mouse.
Rankin SL; Zhu G; Baker SJ
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):254-70. PubMed ID: 22035336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
